Pre-diagnostic awareness of a germline pathogenic variant in BRCA1/2 or PALB2 allows for enhanced screening and risk-reducing mastectomy, the latter of which dramatically lowers the likelihood of being diagnosed with breast cancer [9, 10]. This evidence concerns the gene BRCA1 and breast carcinoma.